Cargando…

Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation

Programmed cell death ligand-1 (PD-L1), expressed on both tumor cells (TC) and tumor-associated immune cells (IC), has been shown to be a useful biomarker and predictive of response to anti-PD-L1 agents in certain tumor types. In recurrent or metastatic head and neck squamous cell carcinoma (R/M HNS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wildsmith, Sophie, Ye, Jiabu, Franks, April, Melillo, Giovanni, Armstrong, Jon, Whiteley, Jessica, Schnittker, Karina, Lian, Fangru, Roland, Bryan, Sabalos, Constantine, Ahmadi, Payam, Fayette, Jerome, Even, Caroline, Mesía, Ricard, Siu, Lillian L., Zandberg, Dan P., Walker, Jill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973403/ https://www.ncbi.nlm.nih.gov/pubmed/36860696 http://dx.doi.org/10.1158/2767-9764.CRC-21-0032

Ejemplares similares

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wildsmith, Sophie, et al.
Publicado: (2023)

Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR
por: Gilbert, Jill, et al.
Publicado: (2015)

Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): eagle
por: Ferris, Robert L, et al.
Publicado: (2015)

Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma
por: Rebelatto, Marlon C., et al.
Publicado: (2016)

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Taberna, Miren, et al.
Publicado: (2019)

Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck()
por: de Llobet, Lara I., et al.
Publicado: (2014)

Relationship Between Progression‐Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD‐1/PD‐L1 Immune Checkpoint Blockade: A Meta‐Analysis
por: Ye, Jiabu, et al.
Publicado: (2020)

Season of birth and depression in adulthood: Revisiting historical forerunner evidence for in-utero effects
por: Schnittker, Jason
Publicado: (2018)

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions
por: Guigay, Joël, et al.
Publicado: (2019)

Optimal PD-L1–high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy
por: Zajac, Magdalena, et al.
Publicado: (2020)

The Increasing Predictive Validity of Self-Rated Health
por: Schnittker, Jason, et al.
Publicado: (2014)

Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma
por: García-Foncillas, Jesús, et al.
Publicado: (2022)

Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case report
por: Mesía, Ricard, et al.
Publicado: (2010)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
por: Oliva, M, et al.
Publicado: (2019)

Oncostatin M and TLR-4 Ligand Synergize to Induce MCP-1, IL-6, and VEGF in Human Aortic Adventitial Fibroblasts and Smooth Muscle Cells
por: Schnittker, David, et al.
Publicado: (2013)

SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
por: Pai, Sara I., et al.
Publicado: (2019)

Neither mad nor bad? The classification of antisocial personality disorder among formerly incarcerated adults
por: Schnittker, Jason, et al.
Publicado: (2020)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
por: Lopez-Beltran, Antonio, et al.
Publicado: (2021)

The contingent effect of incarceration on state health outcomes
por: Uggen, Christopher, et al.
Publicado: (2022)

Opioid-Induced Constipation in Oncological Patients: New Strategies of Management
por: Mesía, Ricard, et al.
Publicado: (2019)

Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution
por: Fontanals, Sandra, et al.
Publicado: (2023)

Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain
por: Arrazubi, Virginia, et al.
Publicado: (2022)

Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer
por: Jasani, Bharat, et al.
Publicado: (2020)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Short Article “Villages … Reek of Ether Vapours”: Ether Drinking in Silesia before 1939
por: ZANDBERG, ADRIAN
Publicado: (2010)

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03
por: Fayette, Jerome, et al.
Publicado: (2017)

A systematic literature review of real-world treatment outcomes of small cell lung cancer
por: Stokes, Michael, et al.
Publicado: (2022)

Emergence and migration of trunk neural crest cells in a snake, the California Kingsnake (Lampropeltis getula californiae)
por: Reyes, Michelle, et al.
Publicado: (2010)

Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors
por: Arribas, Lorena, et al.
Publicado: (2021)

Identification of Novel Immune Cell-Relevant Therapeutic Targets and Validation of Roles of TK1 in BMSCs of Systemic Lupus Erythematosus
por: Chen, Fangru, et al.
Publicado: (2022)

A230 A MISSENSE MUTATION IN GOBLET CELL PROTEIN FCGBP ALTERS THE GLYCOMIC PROFILE AND FUNCTION OF THE COLONIC MUCUS BARRIER
por: Gorman, H, et al.
Publicado: (2023)

Complete genome sequence of Staphylococcus casei strain DSM 15096
por: Wildsmith, Caitlin, et al.
Publicado: (2023)

La relativización en castellano /
por: Mesía, Wilfredo
Publicado: (1970)

The Multidisciplinary Team (MDT) Approach and Quality of Care
por: Taberna, Miren, et al.
Publicado: (2020)

Do young men's reports of hormonal and long-acting contraceptive method use match their female partner's reports?()
por: Karberg, Elizabeth, et al.
Publicado: (2019)

The relationship context of nonmarital childbearing in the U.S.
por: Manlove, Jennifer, et al.
Publicado: (2010)

Improving mental regeneration after physical exercise
por: Jäger, Ralf, et al.
Publicado: (2008)

The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis
por: Balart, Josep, et al.
Publicado: (2011)

Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents
por: Antelo, Gabriela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h4ls7jdb2dm8apeu905t37fu0b